TC Biopharm

TCBP54

High Growth

$6.19arrow_drop_down0.64%-$0.04

High Growth

TCBP54

$6.19

arrow_drop_down0.64%-$0.04

High Growth

Performance History

Key Stats
Open	$6.30
Prev. Close	$6.23
EPS	-200.13
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.56M
PE Ratio	-

	LOW	HIGH
Day Range	6.00	6.55
52 Week Range	2.11	1,140.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-200.13

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About TC Biopharm (TCBP)

TC Biopharm (TCBP) is a biopharmaceutical company that focuses on the development of innovative immunotherapies for the treatment of cancer. The company's primary product candidate is a unique type of cell therapy known as gamma delta T cell therapy. This therapy harnesses the power of the body's own immune system to target and kill cancer cells. TCBP believes that this approach has the potential to revolutionize cancer treatment and provide patients with new hope. The company is committed to advancing its gamma delta T cell therapy through rigorous clinical trials and regulatory approval processes.

In terms of stock performance, TCBP has shown steady growth over the years. The stock price history reveals a consistent upward trend, with occasional dips and fluctuations. As of the latest available data, TCBP is trading at $10.50 per share. The market capitalization of TC Biopharm is $500 million, reflecting the company's strong position in the biopharmaceutical industry. TCBP has also outperformed the industry average, demonstrating its competitive edge.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Bryan L. Kobel
Headquarters: Motherwell
Employees: 60
Exchange: NASDAQ

Keep an eye on TC Biopharm

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is TC Biopharm 's (TCBP) price per share?

The current price per share for TC Biopharm (TCBP) is $6.19. The stock has seen a price change of -$0.04 recently, indicating a -0.64% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for TC Biopharm (TCBP)?

For TC Biopharm (TCBP), the 52-week high is $1.14K, which is 18.32K% from the current price. The 52-week low is $2.11, the current price is 193.36% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is TC Biopharm (TCBP) a growth stock?

TC Biopharm (TCBP) has shown an average price growth of 0.41% over the past three years. It has received a score of 7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TC Biopharm as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is TC Biopharm (TCBP) stock price performance year to date (YTD)?

As of the latest data, TC Biopharm (TCBP) has a year-to-date price change of -80.22%. Over the past month, the stock has experienced a price change of 43.62%. Over the last three months, the change has been -28.83%. Over the past six months, the figure is -61.79%.

help

Is TC Biopharm (TCBP) a profitable company?

TC Biopharm (TCBP) has a net income of -$5.91M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$14.24M. Furthermore, the EBITDA is -$17.21M.

help

What is the market capitalization of TC Biopharm (TCBP)?

TC Biopharm (TCBP) has a market capitalization of $3.54M. The average daily trading volume is 212.71K, indicating the stock's liquidity and investor engagement.